Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ISIS PHARMACEUTICALS INC Key Ratios

  • Valuation Ratio: ISIS

    P/E (TTM) -109.08
    Price to CashFlow -3.47
    Price to Sales (TTM) 12.51
    Price to Book 4.89
  • Per Share Ratio: ISIS

    Dividend Per Share (TTM) 0.00
    Book Value Per Share 0.59
    EPS Fully Diluted -0.13
    Revenue Per Share 1.13
  • 5 Year Annual Growth: ISIS

    Net Income
    Revenue 16.48%
    Dividend Per Share (TTM) 0.00%
    EPS
  • Dividends: ISIS

    Dividend Yield 0.00%
    Dividend Yield - 5 Yr. Avg. 0.00%
    Dividend Per Share (TTM) 0.00
    Dividend Payout Ratio 0.00
  • Profit Margins: ISIS

    Operations Margin -12.18%
    Net Profit Margin -11.16%
    Gross Profit Margin 93.64%
  • Financial Strength: ISIS

    Quick Ratio (MRQ) 3.97
    Current Ratio (MRQ) 5.40
    LT Debt to Equity (MRQ) 46.35
    Total Debt to Equity (MRQ) 47.75
    Return on Equity (ROE) Per Share -37.12
    Return on Assets (ROA) 24.89
    Return on Invested Capital (ROIC) -3.62
  • Assets: ISIS

    Asset Turnover 0.19
    Inventory Turnover 38.73